A research team led at Texas A&M University reports a nasal spray therapy that reverses signs of brain aging in preclinical models. Age-related brain inflammation, sometimes called neuroinflammaging, can harm memory and increase risk of disorders such as Alzheimer’s disease.
The spray delivers millions of extracellular vesicles (EVs) carrying microRNAs directly to the brain through intranasal delivery. This route lets the EVs bypass the brain’s protective barrier and enter brain tissue. In two doses the treatment reduced inflammation, reactivated neuronal mitochondria and lowered oxidative stress, which improved the brain’s ability to process and store information.
Tests showed treated models did better at recognising familiar objects and detecting new objects or changes, and the results were similar in both sexes. The team published the findings in a scientific journal, filed a US patent, and received support from the National Institute on Aging. Further work is needed to assess safety, dosing and effects in humans.
Difficult words
- preclinical — before human testing, done in lab or animals
- neuroinflammaging — long-term inflammation in the brain with aging
- extracellular vesicle — small particles released by cells that carry moleculesextracellular vesicles
- microRNA — tiny pieces of genetic material that control genesmicroRNAs
- intranasal delivery — giving medicine through the nose to the brain
- mitochondrion — cell part that makes energy for nerve cellsmitochondria
- oxidative stress — cell damage caused by reactive oxygen molecules
- recognise — see or remember something seen beforerecognising
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- What concerns would you have about using this nasal spray in people? Explain briefly.
- Why is it important to study safety, dosing and effects in humans before using a new treatment?
- If this treatment worked in people, how could it change life for older adults?
Related articles
Brown study suggests targeting mTORC2 could help fight cancer
Researchers at Brown University report that blocking the mTORC2 protein complex, while leaving mTORC1 active, may stop cancer growth signals without triggering survival pathways. The work offers a new direction for designing cancer drugs.
Wearable 10‑Minute Antibody Sensors from University of Pittsburgh
Researchers at the University of Pittsburgh made a wearable biosensor that detects antibodies in interstitial fluid in 10 minutes without a blood draw. The tiny carbon nanotube sensors are highly sensitive and the work appears in Analytical Chemistry.
New device measures blood viscosity in real time
Researchers at the University of Missouri created a non-invasive device that monitors blood viscosity and density in real time using ultrasound and software. It can read blood without drawing samples and may help in diseases like sickle cell.
